Literature DB >> 35482052

[Management of FAIS in professional soccer athletes and return to sports].

Stefan Budde1, Marco Ezechieli2.   

Abstract

The prevalence of femoroacetabular impingement syndrome in professional soccer athletes is high. Professional training and treatment conditions ensure an effective conservative therapy focusing on dynamic stability, motion control, muscle balance and core stability. In the case of persistent limitations, indication for surgery has to be considered carefully. The probability is high that return to a professional level of soccer is feasible. However, the period of rehabilitation is long, leading to a potential conflict area between economic and medical interests. Good communication and intensive patient education are essential.
© 2022. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Conservative treatment; Femoroacetabular impingement syndrome; Resumption of sporting activity; Sports medicine; Surgical procedure

Mesh:

Year:  2022        PMID: 35482052     DOI: 10.1007/s00132-022-04257-2

Source DB:  PubMed          Journal:  Orthopadie (Heidelb)        ISSN: 2731-7145


  3 in total

Review 1.  [Femoroacetabular impingement: rehabilitation and return to sport].

Authors:  S Gard; P Christofilopoulos; J Ménétrey
Journal:  Rev Med Suisse       Date:  2015-07-15

2.  Morphologic features of congenital acetabular dysplasia: one in six is retroverted.

Authors:  Patrick L S Li; Reinhold Ganz
Journal:  Clin Orthop Relat Res       Date:  2003-11       Impact factor: 4.176

3.  A Prospective, Randomized, Controlled Trial Comparing Conservative Treatment With Trunk Stabilization Exercise to Standard Hip Muscle Exercise for Treating Femoroacetabular Impingement: A Pilot Study.

Authors:  Michihisa Aoyama; Yasuo Ohnishi; Hajime Utsunomiya; Shiho Kanezaki; Hiroki Takeuchi; Makoto Watanuki; Dean K Matsuda; Soshi Uchida
Journal:  Clin J Sport Med       Date:  2019-07       Impact factor: 3.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.